VISTAGEN THERAPEUTICS INC's ticker is VTGN and the CUSIP is 92840H202. A total of 12 filers reported holding VISTAGEN THERAPEUTICS INC in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $112,000 | -40.1% | 162,714 | -6.9% | 0.00% | 0.0% |
| Q3 2019 | $187,000 | +48.4% | 174,714 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $126,000 | -43.8% | 174,714 | -0.1% | 0.00% | -50.0% |
| Q1 2019 | $224,000 | +9.8% | 174,914 | +28.5% | 0.00% | 0.0% |
| Q4 2018 | $204,000 | +13.3% | 136,114 | +9.2% | 0.00% | 0.0% |
| Q3 2018 | $180,000 | +85.6% | 124,614 | +19.3% | 0.00% | +100.0% |
| Q2 2018 | $97,000 | 0.0% | 104,414 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $97,000 | -16.4% | 104,414 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $116,000 | +61.1% | 104,414 | +131.6% | 0.00% | 0.0% |
| Q3 2017 | $72,000 | -14.3% | 45,076 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $84,000 | -4.5% | 45,076 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $88,000 | +144.4% | 45,076 | +371.7% | 0.00% | 0.0% |
| Q4 2016 | $36,000 | -10.0% | 9,556 | 0.0% | 0.00% | 0.0% |
| Q3 2016 | $40,000 | +37.9% | 9,556 | +28.4% | 0.00% | – |
| Q2 2016 | $29,000 | – | 7,441 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACUTA CAPITAL PARTNERS, LLC | 11,728,033 | $32,135,000 | 11.34% |
| VR Adviser, LLC | 16,047,286 | $43,970,000 | 5.65% |
| COMMODORE CAPITAL LP | 5,123,509 | $14,038,000 | 3.70% |
| Ghost Tree Capital, LLC | 2,000,000 | $5,480,000 | 1.60% |
| EPIQ PARTNERS, LLC | 916,100 | $2,510,000 | 1.16% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 707,733 | $1,939,000 | 1.10% |
| SPHERA FUNDS MANAGEMENT LTD. | 3,824,938 | $10,480,000 | 0.88% |
| HighVista Strategies LLC | 438,239 | $1,201,000 | 0.80% |
| Nicholas Investment Partners, LP | 2,786,354 | $7,635,000 | 0.56% |
| NEA Management Company, LLC | 16,302,596 | $44,669,000 | 0.53% |